tirzepatide once weekly for the treatment of obesity journal club Updates Tirzepatide (Zepbound) for the Treatment
Description
Report any new or worsening symptoms, share your weight loss progress, and discuss whether 15 mg remains the appropriate dose for your situation
In addition, they have effects on adipose cells, bone, and the cardiovascular system
Tirzepatide (Mounjaro for type 2 diabetes, Zepbound for weight management) is an FDA-approved dual GIP and GLP-1 receptor agonist that effectively controls blood glucose and promotes weight loss
Aim for 0.7-1 gram per pound of target body weight daily
Side by side One compound targets hunger
Avoiding high-fat, greasy, or heavily spiced foods during dose escalation helps significantly
